HIGHLIGHTS
- who: Zhimin Lin et al. from the Department of General Surgery, Hospital of Joint Logistics Support Force, Fujian, Fuzhou, China Fuzhou General Clinical Medical College of Fujian Medical University, Fujian, Fuzhou, China have published the research work: Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma, in the Journal: Mediators of Inflammation 0.4 of 29/09/2022
- what: The authors first analyzed the relationship between the PTPRO expression and prognosis in LUAD and further explored the correlation between PTPRO and clinical characteristics. The previous results of this study showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.